Related Experiment Video
Updated: May 21, 2026

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
Published on: September 5, 2019
Targeting peroxiredoxins against leukemia
Chuan-Xu Liu1, Hu-Chen Zhou, Qian-Qian Yin
1Department of Pathophysiology, Shanghai Univeristies E-Institute for Chemical Biology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Abstract:
Peroxiredoxins (Prx), a family of small non-seleno peroxidases, are important regulators for cellular reactive oxygen species (ROS), which contribute to many signaling pathways and pathogenesis of diseases. Targeting redox homeostasis is being developed as a promising therapeutic strategy for many diseases such as cancers. This mini-review attempts to focus on our recent discoveries on adenanthin as the first natural molecule to specifically target the resolving cysteines of Prx I and Prx II and thus inhibit their peroxidase activities, and its role in differentiation induction in vitro and in vivo of acute myeloid leukemic cells.
Insights
Adenanthin is a natural molecule that inhibits peroxidase activities of Peroxiredoxins (Prx) I and II. This discovery offers a new therapeutic strategy for acute myeloid leukemia by inducing cell differentiation.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Peroxiredoxins (Prx) regulate cellular reactive oxygen species (ROS), impacting signaling and disease pathogenesis.
- Redox homeostasis is a key therapeutic target for diseases, including cancers.
Purpose of the Study:
- To review recent discoveries on adenanthin as a novel therapeutic agent.
- To highlight adenanthin's specific targeting of Peroxiredoxin I and II (Prx I/II) resolving cysteines.
- To explore adenanthin's role in inducing differentiation of acute myeloid leukemia (AML) cells.
Main Methods:
- Literature review of recent discoveries on adenanthin and Prx.
- Analysis of adenanthin's mechanism of action on Prx I/II peroxidase activity.
- Evaluation of adenanthin's effects on AML cell differentiation in vitro and in vivo.
Main Results:
- Adenanthin identified as the first natural molecule to specifically inhibit Prx I and Prx II.
- Adenanthin effectively targets the resolving cysteines of Prx I/II, reducing their peroxidase activity.
- Adenanthin demonstrated efficacy in inducing differentiation of acute myeloid leukemic cells both in vitro and in vivo.
Conclusions:
- Adenanthin represents a promising natural therapeutic candidate for targeting Prx-mediated redox signaling.
- Inhibition of Prx activity by adenanthin offers a novel strategy for treating acute myeloid leukemia.
- Adenanthin's ability to induce differentiation provides a potential mechanism for its anti-leukemic effects.
Related Concept Videos
Peroxisomes
Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within peroxisomes...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Redox Reactions

